This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Oxford University Innovation Ltd. Active years: 2019-2024.
Company Filing History:
Years Active: 2019-2024
Title: Jürgen Brem: Innovator in Antibiotic Research
Introduction
Jürgen Brem is a notable inventor based in Oxford, GB. He has made significant contributions to the field of antibiotic research, particularly in the development of β-lactamase inhibitors. With a total of 4 patents to his name, his work has the potential to impact the treatment of bacterial infections.
Latest Patents
One of his latest patents focuses on β-lactamase inhibitors. This invention relates to the use of specific β-lactamase inhibitors in conjunction with one or more ⊕-lactam antibiotics for the treatment of tuberculosis or infections. Another significant patent involves inhibitors of metallo-beta-lactamases. This invention pertains to certain compounds, particularly indole derivatives, that act as inhibitors of bacterial metallo-beta-lactamases. It also includes processes for the preparation of these compounds, pharmaceutical compositions containing them, and their application in treating bacterial infections.
Career Highlights
Jürgen Brem is associated with Oxford University Innovation Limited, where he continues to advance his research and innovations. His work is crucial in addressing the challenges posed by antibiotic resistance.
Collaborations
He has collaborated with notable colleagues, including Christopher Joseph Schofield and Michael Arnold McDonough, to further enhance the impact of his research.
Conclusion
Jürgen Brem's contributions to antibiotic research through his innovative patents highlight his role as a key figure in the fight against bacterial infections. His work continues to pave the way for new treatment options in the medical field.